Evaluation of Photodynamic Therapy in patients with Diabetes
- Conditions
- diabetes mellitusperiodontitisC18.452.394.968.500.570
- Registration Number
- RBR-7pn5prj
- Lead Sponsor
- niversidade Federal Fluminense
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Participants over 18 years old; type 2 diabetics; periodontal disease with pockets with probing depth greater than 5 mm
hypersensitivity to the components of chlorhexidine gel or methylene blue and laser therapy and any evidence of systemic modifying factors of periodontal disease; except diabetics; osteoporosis types I and II; alcoholism; acquired or induced immunosuppression; any change described in the literature as potentially modifying the profile of periodontal disease; physical/emotional stress; medications that influence periodontal tissues. Samples from pregnant or lactating women; participants who have taken antibiotics in the last 6 months; clinical manifestations of oral candidosis; anti-inflammatories or hormone replacement therapy; and/or who have received periodontal treatment in the last six months prior to the procedure will be excluded
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find an average difference in periodontal pocket smaller than five millimeters
- Secondary Outcome Measures
Name Time Method It is expected to find similar results to periodontal treatment in terms of clinical response and reduction in clinical parameters after periodontal treatment for both sites evaluated, test and placebo.